抗抑郁药在重度抑郁症中的融合功能作用:神经成像元分析
Amin Saberi1,2,3, Amir Ebneabbasi4,5, Sama Rahimi1,2,6
1Institute of Neurosciences and Medicine (INM-7), Research Centre Jülich, Jülich, Germany.
Molecular psychiatry
|October 15, 2024
概括
这项研究发现,抗抑郁药对前端对象网络,特别是左侧前额叶皮质产生影响,改善了严重抑郁症患者的执行功能. 没有发现与神经递质系统的直接联系.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 神经成像是一种神经成像.
背景情况:
- 重度抑郁症 (MDD) 治疗通常涉及抗抑郁药物,但神经成像发现不一致.
- 以前的研究提供了对抗抑郁药对大脑功能影响的见解,但缺乏共识.
- 这次元分析综合了功能神经成像数据,以确定与MDD抗抑郁药物治疗相关的一致的大脑变化.
研究的目的:
- 对MDD中抗抑郁药效应的功能神经成像研究进行定量合成.
- 为了确定融合的区域和网络水平的大脑变化.
- 探索这些变化与神经递质系统之间的关联.
主要方法:
- 一项全面的文献搜索确定了36项符合条件的研究.
- 激活概率估计 (ALE) 绘制了抗抑郁药效应的区域趋同.
- 进行了功能解码,连接映射和与跨磁刺激 (TMS) 电路进行比较.
主要成果:
- 在所有研究中都没有发现总体的区域趋同.
- 在子组分析中,左背侧前额叶皮层 (dlPFC) 中出现了一个收集群,与执行功能有关.
- 网络层面的趋同确定了一个前端对称电路,与TMS目标保持一致,但没有观察到与神经递质系统的相关性.
结论:
- 面对对面的网络和左 dlPFC 对抗抑郁药在 MDD 的治疗效果至关重要.
- 这些大脑区域都与改善执行功能和情绪处理有关.
- 这些发现强调了抗抑郁药在网络层面的影响,可能指导未来的治疗策略.
更多相关视频
07:12Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
3.5K
10:43Developing Neuroimaging Phenotypes of the Default Mode Network in PTSD: Integrating the Resting State, Working Memory, and Structural Connectivity
Published on: July 1, 2014
15.0K
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
197
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
197
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
322
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
322
Brain Imaging
216
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
216
Depression: Overview
222
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
222
Antidepressant Drugs: Overview
372
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
372
